n‐Butanol Enables OMVs as Heat‐Responsive Nanometer Ultrasound Contrast Agents for Tumor Imaging
Source abstract
Abstract
Abstract Extracellular vesicles, such as Escherichia coli outer membrane vesicles (OMVs), have been widely explored as carriers for contrast agents, yet their application in ultrasound imaging remains limited. In this study, heat‐responsive nB‐OMVs are developed by loading n‐butanol into OMVs (nB‐OMVs). Upon heating, the decreased solubility of n‐butanol triggered phase separation within the vesicles, resulting in enhanced ultrasound signals, including fundamental, harmonic, and subharmonic components. Experimental results demonstrated that nB‐OMVs retained the native morphology of OMVs, along with their tumor‐targeting accumulation and tumor growth inhibition capabilities. nB‐OMVs injection induces red blood cell extravasation into tumors, under near‐infrared (NIR) irradiation, these extravasated RBCs acted as photothermal mediators, generating a localized thermal environment that activated intratumoral nB‐OMVs and further amplified the ultrasound signal. In B‐mode and contrast‐enhanced ultrasound (CEUS) imaging, tumor grayscale intensities increased by 4.6‐ and 8.5‐fold, respectively. This work provides a promising strategy for ultrasound‐based tumor imaging using extracellular vesicles.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Photoacoustic and Ultrasonic Imaging · Ultrasound and Hyperthermia Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Ultrasound in Medicine and Engineering College of Biomedical Engineering Chongqing Medical University Chongqing 400016 China
References (61)
Show source-provided references
1. 10.1002/adfm.20180449210.1002/adfm.201804492 ↗
2. 10.1002/adhm.20190115510.1002/adhm.201901155 ↗
3. 10.1002/adfm.20240809910.1002/adfm.202408099 ↗
4. 10.1021/acsnano.4c0104110.1021/acsnano.4c01041 ↗
5. 10.1016/j.cocis.2021.10146310.1016/j.cocis.2021.101463 ↗
6. 10.1016/j.biomaterials.2023.12218110.1016/j.biomaterials.2023.122181 ↗
7. 10.1016/j.biomaterials.2023.12202510.1016/j.biomaterials.2023.122025 ↗
8. 10.1002/advs.20230087810.1002/advs.202300878 ↗
9. 10.1002/adma.20231042110.1002/adma.202310421 ↗
10. 10.1002/adma.20150202210.1002/adma.201502022 ↗
11. 10.34133/bmef.004010.34133/bmef.0040 ↗
12. 10.1016/j.nantod.2023.10207610.1016/j.nantod.2023.102076 ↗
13. 10.1021/acs.langmuir.9b0364710.1021/acs.langmuir.9b03647 ↗
14. 10.1016/j.actbio.2021.12.01210.1016/j.actbio.2021.12.012 ↗
15. 10.1016/j.addr.2024.11520010.1016/j.addr.2024.115200 ↗
16. 10.1016/j.mtbio.2023.10055610.1016/j.mtbio.2023.100556 ↗
17. 10.1186/s12951-023-02133-510.1186/s12951-023-02133-5 ↗
18. 10.3390/pharmaceutics1504105210.3390/pharmaceutics15041052 ↗
19. 10.1016/j.jconrel.2020.04.03110.1016/j.jconrel.2020.04.031 ↗
20. 10.1016/j.apsb.2020.02.00210.1016/j.apsb.2020.02.002 ↗
21. 10.3390/cancers1211338610.3390/cancers12113386 ↗
22. 10.1002/adma.20200208510.1002/adma.202002085 ↗
23. 10.1038/s41467-019-09034-y10.1038/s41467-019-09034-y ↗
24. 10.1021/acs.analchem.4c0444910.1021/acs.analchem.4c04449 ↗
25. 10.1016/j.bpj.2016.11.320510.1016/j.bpj.2016.11.3205 ↗
26. 10.1021/je00043a01910.1021/je00043a019 ↗
27. 10.1021/acs.langmuir.4c0149910.1021/acs.langmuir.4c01499 ↗
28. 10.1016/j.cis.2022.10277810.1016/j.cis.2022.102778 ↗
29. 10.1016/j.biomaterials.2020.12055010.1016/j.biomaterials.2020.120550 ↗
30. 10.2217/nnm.14.5610.2217/nnm.14.56 ↗
31. 10.1016/j.biomaterials.2020.12046710.1016/j.biomaterials.2020.120467 ↗
32. 10.1016/j.tim.2023.05.01010.1016/j.tim.2023.05.010 ↗
33. 10.1016/j.ultrasmedbio.2020.04.03810.1016/j.ultrasmedbio.2020.04.038 ↗
34. 10.1016/j.ultras.2012.03.00710.1016/j.ultras.2012.03.007 ↗
35. 10.1016/j.ultrasmedbio.2020.04.01410.1016/j.ultrasmedbio.2020.04.014 ↗
36. 10.1038/s41598-019-46112-z10.1038/s41598-019-46112-z ↗
37. 10.1016/j.chemphyslip.2020.10498610.1016/j.chemphyslip.2020.104986 ↗
38. 10.1021/cr60274a00110.1021/cr60274a001 ↗
39. 10.1016/j.mpaic.2020.11.01210.1016/j.mpaic.2020.11.012 ↗
40. 10.1021/acs.langmuir.9b0284210.1021/acs.langmuir.9b02842 ↗
41. 10.1002/smll.20130284610.1002/smll.201302846 ↗
42. 10.1021/js950407f10.1021/js950407f ↗
43. 10.1039/D2BM01140A10.1039/D2BM01140A ↗
44. 10.1038/s41598-018-29018-010.1038/s41598-018-29018-0 ↗
45. 10.1016/j.critrevonc.2024.10454110.1016/j.critrevonc.2024.104541 ↗
46. 10.1016/j.nantod.2022.10159110.1016/j.nantod.2022.101591 ↗
47. 10.1038/s41598-023-45628-910.1038/s41598-023-45628-9 ↗
48. 10.1038/s41467-017-00729-810.1038/s41467-017-00729-8 ↗
49. 10.1016/j.ymthe.2020.10.00910.1016/j.ymthe.2020.10.009 ↗
50. Jin L. · Acta Biochim. Biophys. Sin. (Shanghai) · 2022 · 54 · 1301
51. 10.1186/s40824-022-00270-w10.1186/s40824-022-00270-w ↗
52. 10.1177/175342591880800810.1177/1753425918808008 ↗
53. 10.1016/j.cell.2016.04.01510.1016/j.cell.2016.04.015 ↗
54. 10.1016/j.nantod.2023.10207610.1016/j.nantod.2023.102076 ↗
55. 10.1039/D0NA00339E10.1039/D0NA00339E ↗
56. Li X. · Nanomicro Lett. · 2019 · 11 · 68
57. 10.1039/D4MH00819G10.1039/D4MH00819G ↗
58. 10.1016/j.ultrasmedbio.2024.09.00810.1016/j.ultrasmedbio.2024.09.008 ↗
59. 10.1016/j.jep.2020.11334710.1016/j.jep.2020.113347 ↗
60. 10.1016/j.ultrasmedbio.2017.10.01110.1016/j.ultrasmedbio.2017.10.011 ↗
61. 10.1021/acs.biomac.8b0113310.1021/acs.biomac.8b01133 ↗